Evidence map›Paper›PMID 23378531›Full record

ArticleThe Journal of biological chemistry2013

Mitochondria and the lectin pathway of complement.

Christel R Brinkmann, Lisbeth Jensen, Frederik Dagnæs-Hansen, Ida E Holm, Yuichi Endo, Teizo Fujita, Steffen Thiel, Jens C Jensenius, Søren E Degn

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. The Complement System, Aging, and Aging-Related Diseases.International journal of molecular sciences · 2022
    Review
  7. Complement's favourite organelle-Mitochondria?British journal of pharmacology · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Defibrotide in the treatment of hepatic veno-occlusive disease.Hepatic medicine : evidence and research · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Christel R BrinkmannDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark.
Lisbeth JensenDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark.
Frederik Dagnæs-HansenDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark.
Ida E HolmLaboratory for Experimental Neuropathology, Department of Pathology, Randers Hospital, DK-8930 Randers NØ, Denmark; Institute of Clinical Medicine, Aarhus University, DK-8000 Aarhus C, Denmark.
Yuichi EndoDepartment of Immunology, Fukushima Medical University, 1-Hikariga-oka, Fukushima City, Fukushima 960-1295, Japan.
Teizo FujitaDepartment of Immunology, Fukushima Medical University, 1-Hikariga-oka, Fukushima City, Fukushima 960-1295, Japan.
Steffen ThielDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark.
Jens C JenseniusDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark.
Søren E DegnDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, DK-8000 Aarhus C, Denmark. Electronic address: sdegn@microbiology.au.dk.
Aarhus University · DKFukushima Medical University · JPRegional Hospital Randers · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria, the powerhouses of our cells, are remnants of a eubacterial endosymbiont. Notwithstanding the evolutionary time that has passed since the initial endosymbiotic event, mitochondria have retained many hallmarks of their eubacterial origin. Recent studies have indicated that during perturbations of normal homeostasis, such as following acute trauma leading to massive necrosis and release of mitochondria, the immune system might mistake symbiont for enemy and initiate an inappropriate immune response. The innate immune system is the first line of defense against invading microbial pathogens, and as such is the primary suspect in the recognition of mitochondria-derived danger-associated molecular patterns and initiation of an aberrant response. Conversely, innate immune mechanisms are also central to noninflammatory clearance of innocuous agents. Here we investigated the role of a central humoral component of innate immunity, the lectin pathway of complement, in recognition of mitochondria in vitro and in vivo. We found that the soluble pattern recognition molecules, mannan-binding lectin (MBL), L-ficolin, and M-ficolin, were able to recognize mitochondria. Furthermore, MBL in complex with MBL-associated serine protease 2 (MASP-2) was able to activate the lectin pathway and deposit C4 onto mitochondria, suggesting that these molecules are involved either in homeostatic clearance of mitochondria or in induction of untoward inflammatory reactions. We found that following mitochondrial challenge, C3 was consumed in vivo in the absence of overt inflammation, indicating a potential role of complement in noninflammatory clearance of mitochondria. Thus, we report here the first indication of involvement of the lectin pathway in mitochondrial immune handling.

Indexed as

Complement Pathway, Mannose-Binding LectinAnimalsBlood ProteinsComplement C3Complement C4FicolinsHumansInterleukin-6LectinsLipopolysaccharidesLungMannose-Binding LectinMannose-Binding Protein-Associated Serine ProteasesMiceMice, Inbred C57BLMice, KnockoutBlood ProteinsComplement C3Complement C4FicolinsInterleukin-6LectinsLipopolysaccharidesMannose-Binding LectinMannose-Binding Protein-Associated Serine ProteasesMasp2 protein, ratReceptors, Pattern Recognition

Identifiers

PMID23378531
PMCPMC3605621
OpenAlexW1964665929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.